Skip to the story
All StoriesPoliticsConflict & SecurityBusiness & EconomyScience & TechHealthClimateMedia
All stories
Health23 outlets ran this3 min read

England trials blood tests for early cancer diagnosis

A UK government-funded study will assess if blood tests can detect common abdominal cancers in patients aged 45 and over.

AI-assisted coverage comparison, editor-supervised · How this was made

Published
Doctor taking blood from an anonymous woman in a clinic

What this story says

  • A clinical trial in England will test blood tests for early diagnosis of common cancers.
  • The trial involves 20,000 patients from 200 GP practices and is funded by the UK government.
  • Tests developed by the University of Birmingham will look for signs of several abdominal cancers in patients aged 45 and over.
  • The study aims to improve survival rates by detecting cancers earlier when treatment is more effective.

Who covered it

Left 50%(4)Centre 25%(2)Right 25%(2)

Percentages are shares of the 8 outlets carrying a published leaning rating. 15 of the 23 outlets we know ran this story carry no rating and are not counted in them. Coverage measured .

Trust

68/100

Craft

68/100

Hype

45/100

23 sources · methodology

A clinical trial is to be conducted in England to evaluate the use of blood tests for the early detection of common cancers. The study will involve 20,000 patients from 200 general practitioner (GP) practices across the country. Developed by the University of Birmingham, the tests are designed to identify signs of several abdominal cancers. Patients aged 45 and older presenting with abdominal symptoms will be eligible to participate. The trial is supported by government funding, with an estimated cost of £8.49 million.

Disagreement on the number of cancers detected

Reports vary on the number of cancer types the blood tests are designed to detect. Emirates24|7, the Daily Mirror, and Reuters state the tests will look for signs of "several" abdominal cancers. However, Newsit.gr, Iatropedia, and The Droitwich Standard report that the tests can detect 13 types of cancer. RocketNews and BBC News refer to "multi-cancer" blood tests without specifying a number.

What the coverage left out

None of the left-rated digests mention the specific cost estimate of £8.49 million for the trial. The centre-rated digests do not mention the specific cost estimate. The right-rated report does not mention the specific cost estimate of £8.49 million.

Tags:#CancerDiagnosis#NHS#ClinicalTrial#PublicHealth#MedicalResearch

Still developing. We have re-checked which outlets are covering this 7 times, most recently on 4 Nov 2026, 15:30, and will add the sides that appear.

How each side covered it

Our own reading of the reporting listed below, written from the outlets’ articles rather than quoted from them. The reasoning is set out on our methodology page.

Left

4 rated outlets

  • The left-rated reports highlighted the potential for early diagnosis and improved patient outcomes. The Daily Mirror's full report stated that the NHS is launching a trial for a new blood test capable of detecting multiple different cancers, aiming to identify patients who need urgent support sooner. It quoted Health Secretary Yvette Cooper saying, "The earlier cancers are diagnosed, the more chance they can be successfully treated, and lives can be saved." The report also detailed survival rates for bowel cancer at different stages and quoted Professor Peter Johnson, NHS England’s director for cancer, who described the trial as the start of a "revolution in cancer diagnosis." RocketNews's digest noted that the tests are designed to detect multiple types of cancer, particularly abdominal cancers, at earlier stages.

Centre

2 rated outlets

  • The centre-rated reports focused on the trial's aim to detect hard-to-diagnose abdominal cancers earlier. BBC News's digest mentioned the goal to detect cancers such as liver, ovarian, and pancreatic cancer much sooner. Reuters's digest stated that the trial will assess whether family doctors can use simple blood tests to help diagnose some of the most common cancers earlier and boost patients' chances of survival, calling it a "world first."

Right

2 rated outlets

  • Emirates24|7's full report described the trial as a "world first" to assess whether simple blood tests can help general practitioners (GPs) identify patients who need urgent treatment much sooner. It noted that cancer mortality in Britain is among the highest across OECD countries on a per capita basis and that the trial will cover abdominal cancers including prostate, ovarian, bowel, pancreatic, stomach, and liver, which are often diagnosed too late.

Questions about this coverage

How did the left and right cover England trials blood tests for early cancer diagnosis?
Of the 8 outlets on this story carrying a published leaning rating, 50% are rated left, 25% are rated centre, 25% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 23. The sections above set out what each side emphasised, in its own terms.
Is England trials blood tests for early cancer diagnosis left or right?
Too few of the outlets on this story carry a published leaning rating to say. 8 of them do, and this site does not characterise a field under 12: at that size one newsroom filing moves the share by ten points. The percentages above are the count as it stands.
Is the coverage of England trials blood tests for early cancer diagnosis biased?
England trials blood tests for early cancer diagnosis is one event reported by 23 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.
Which outlets covered England trials blood tests for early cancer diagnosis?
23 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.
What is the purpose of the new blood test trial in England?
The trial aims to assess whether family doctors can use simple blood tests to help diagnose common abdominal cancers earlier. The goal is to improve survival rates by detecting cancers at a stage when treatment is more likely to be successful.
How many people will participate in the trial?
The trial is set to involve 20,000 patients. These participants will be recruited from approximately 200 GP practices located across England.
Who is eligible to join the trial?
Patients aged 45 and over who visit their GP with abdominal symptoms are eligible to participate. These symptoms can include persistent bloating or discomfort.
How much funding has the trial received?
The trial is funded by the government and has an estimated cost of £8.49 million. This funding supports the development and execution of the study.

Read it at the source

23 outlets, grouped by the leaning a published rating gives them. Every headline links to the original; an underlined outlet name opens our profile of that publisher.

Left

4

Centre

2

Right

2

Not rated

15
Show 7 more

How did this read?

About the coverage, not about the story. We do not ask whether you agree with what happened — we have no honest use for that answer.

More in Health

All Health →
Jesús de Miguel2 min readJesús de Miguel dies aged 30 after on-field collisionRead storyEnergy drinks linked to cardiac arrest in FDA reports3 min readEnergy drinks linked to cardiac arrest in FDA reportsRead story

Elsewhere on the site

Businesses report Brexit red tape hinders growth, BCC survey findsPolitics•3 min readBusinesses report Brexit red tape hinders growth, BCC survey findsWar memorial vandalised in hate crime investigationPolitics•3 min readWar memorial vandalised in hate crime investigationA trans flag waving over the Supreme Court. (Getty)Politics•2 min readNebraska voters approve constitutional ban on trans athletesTaroltak a demokraták, jelez a kötvénypiac, máris mozdul a dollárBusiness & Economy•3 min readUS Midterms Boost European Stocks, Dollar Weakens
England Cancer Blood Test Trial | MediaBias News